当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析

西藏药业

(600211)

  

流通市值:118.16亿  总市值:118.16亿
流通股本:3.22亿   总股本:3.22亿

西藏药业(600211)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润2.70亿元,每股收益0.84元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益413628.93万元,未分配利润235134.75万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产522220.26万元,负债108591.33万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入712,108,915.52,806,713,295.852,175,443,351.591,614,697,734.98
营业总成本424,599,500.371,865,690,7891,408,185,831.631,028,685,651.52
营业利润302,515,530.491,160,450,276.72884,452,957.66697,332,349.66
利润总额301,647,438.611,152,084,060.44882,826,441.17695,874,085.73
净利润270,248,719.591,057,075,195.66795,146,775.01626,083,557.68
其他综合收益-1,616,882.116,352,053.8-12,079,404.536,723,909.44
综合收益总额268,631,837.491,073,427,249.46783,073,875.81632,807,467.12
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计4,065,129,050.443,569,908,233.163,492,491,291.764,135,022,045.84
非流动资产合计1,157,073,560.111,177,430,107.971,178,542,722.441,200,731,508.97
资产总计5,222,202,610.554,747,338,341.134,671,034,014.25,335,753,554.81
流动负债合计1,052,839,917.62766,571,363.98976,373,627.131,478,888,605.52
非流动负债合计33,073,375.2728,661,867.6230,935,156.5231,716,959.57
负债合计1,085,913,292.89795,233,231.61,007,308,783.651,510,605,565.09
归属于母公司股东权益合计4,101,032,390.123,917,816,533.713,629,963,702.73,791,719,484.95
股东权益合计4,136,289,317.663,952,105,109.533,663,725,230.553,825,147,989.72
负债和股东权益合计5,222,202,610.554,747,338,341.134,671,034,014.25,335,753,554.81
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计835,746,973.163,532,316,583.782,783,019,017.981,917,954,752.4
经营活动现金流出小计525,937,027.592,537,525,771.962,035,757,009.531,323,243,483.33
经营活动产生的现金流量净额309,809,945.57994,790,811.82747,262,008.45594,711,269.07
投资活动现金流入小计1,056,215,668.244,912,682,591.623,577,250,394.82,284,653,027.27
投资活动现金流出小计1,354,801,433.234,558,196,774.613,406,174,323.242,502,650,902.06
投资活动产生的现金流量净额-298,585,764.99354,485,817.01171,076,071.56-217,997,874.79
筹资活动现金流入小计243,970,643.18534,947,148.22434,048,862.95433,040,472.24
筹资活动现金流出小计85,526,605.531,267,939,919.431,050,332,572.98371,704,140.48
筹资活动产生的现金流量净额158,444,037.65-732,992,771.21-616,283,710.0361,336,331.76
汇率变动对现金及现金等价物的影响-1,358,179.417,437,746.19-6,913,756.98700,485.12
现金及现金等价物净增加额168,310,038.82623,721,603.81295,140,613438,750,211.16
期末现金及现金等价物余额1,474,211,204.871,305,901,166.05977,320,175.241,120,929,773.4
TOP↑